Literature DB >> 7595683

Combined high-dose 7S-IgG and dexamethasone is effective in severe polyneuropathy of the POEMS syndrome.

T Henze, G Krieger.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7595683     DOI： 10.1007/BF00873555

Source DB:  PubMed          Journal:  J Neurol        ISSN： 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  6 in total

1.  Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 39-1992. A 49-year-old woman with peripheral neuropathy, hepatosplenomegaly, and intermittent abdominal pain.

Authors: 
Journal:  N Engl J Med       Date:  1992-10-01       Impact factor: 91.245

2.  Improvement in the POEMS syndrome after administration of tamoxifen.

Authors:  T P Enevoldson; A E Harding
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-01       Impact factor: 10.154

3.  A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barré syndrome. Dutch Guillain-Barré Study Group.

Authors:  F G van der Meché; P I Schmitz
Journal:  N Engl J Med       Date:  1992-04-23       Impact factor: 91.245

4.  The Crow-Fukase syndrome: a study of 102 cases in Japan.

Authors:  T Nakanishi; I Sobue; Y Toyokura; H Nishitani; Y Kuroiwa; E Satoyoshi; T Tsubaki; A Igata; Y Ozaki
Journal:  Neurology       Date:  1984-06       Impact factor: 9.910

5.  Plasma-cell dyscrasia with polyneuropathy. The spectrum of POEMS syndrome.

Authors:  G D Miralles; J R O'Fallon; N J Talley
Journal:  N Engl J Med       Date:  1992-12-31       Impact factor: 91.245

6.  Plasma cell dyscrasia with polyneuropathy, organomegaly, endocrinopathy, M protein, and skin changes: the POEMS syndrome. Report on two cases and a review of the literature.

Authors:  P A Bardwick; N J Zvaifler; G N Gill; D Newman; G D Greenway; D L Resnick
Journal:  Medicine (Baltimore)       Date:  1980-07       Impact factor: 1.889
  6 in total
  4 in total

Review 1.  Intravenous immunoglobulin in therapy of peripheral neuropathy.

Authors:  Alexander Gorshtein; Yair Levy
Journal:  Clin Rev Allergy Immunol       Date:  2005-12       Impact factor: 8.667

2.  Poor response to intravenous immunoglobulin therapy in patients with Castleman's disease and the POEMS syndrome.

Authors:  C C Huang; C C Chu
Journal:  J Neurol       Date:  1996-10       Impact factor: 4.849

3.  Current therapies for neuromuscular manifestations of paraneoplastic syndromes.

Authors:  Myrna R Rosenfeld; Josep Dalmau
Journal:  Curr Neurol Neurosci Rep       Date:  2006-01       Impact factor: 5.081

Review 4.  Treatment of POEMS syndrome.

Authors:  Angela Dispenzieri; Morie A Gertz
Journal:  Curr Treat Options Oncol       Date:  2004-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.